chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Headache, Illness
Clinical narrative: dizziness; very ill feeling; sharp headaches; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Stroke (Experienced double stroke).    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches). At the time of the report, DIZZINESS (dizziness), ILLNESS (very ill feeling) and HEADACHE (sharp headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Epistaxis, Fatigue
Clinical narrative: Nose bleed 3-4 times a day until today; Dizziness; tiredness; This spontaneous case was reported by a consumer and describes the occurrence of EPISTAXIS (Nose bleed 3-4 times a day until today), DIZZINESS (Dizziness) and FATIGUE (tiredness) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, the patient experienced EPISTAXIS (Nose bleed 3-4 times a day until today), DIZZINESS (Dizziness) and FATIGUE (tiredness). At the time of the report, EPISTAXIS (Nose bleed 3-4 times a day until today), DIZZINESS (Dizziness) and FATIGUE (tiredness) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant Concomitant medications were reported. No Treatment information provided.
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Missed to receive the dose of the vaccine past 8 weeks; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed to receive the dose of the vaccine past 8 weeks) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed to receive the dose of the vaccine past 8 weeks). On 01-Apr-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed to receive the dose of the vaccine past 8 weeks) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash
Clinical narrative: 2 x 3 inch rash; Headache; This spontaneous case was reported by a consumer and describes the occurrence of RASH (2 x 3 inch rash) and HEADACHE (Headache ) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 070A21A and 019B21A) for COVID-19 vaccination.     The patient's past medical history included Sleep disorder. Concurrent medical conditions included Drug allergy (Tetracycline and Calcium blocker.). Concomitant products included AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL) for Idiopathic hypersomnia, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) for Stress.   On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Mar-2021, the patient experienced RASH (2 x 3 inch rash) and HEADACHE (Headache ). On 11-Mar-2021, RASH (2 x 3 inch rash) and HEADACHE (Headache ) had resolved.            No treatment medication was provided  Action taken with mRNA-1273 Moderna vaccine was Not applcable   This case was linked to MOD-2021-066858 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received and contains patient demographics, allergies , concomitant medicine indication- dosage details and Outcome of the events (unknown-recovered); Sender's Comments:  MOD-2021-066858:Dose 2
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Patient is pregnant; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Patient is pregnant) in a 36-year-old female patient (gravida 1, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism since 2006 and Sjogren's syndrome since 2007. Concomitant products included LEVOTHYROXINE for Hypothyroidism, POTASSIUM for Nutritional supplement.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 01-Oct-2020 and the estimated date of delivery was 09-Jul-2021. On 02-Apr-2021, the patient experienced EXPOSURE DURING PREGNANCY (Patient is pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  twenty-sixth week of the pregnancy. The delivery occurred on an unknown date. For neonate 1, Patient Pre pregnancy weight was 130 Pounds and Patient had no maternal history of subfertility. Estimated Date of Conception was reported as 12-Oct-2020. At the time of the report, EXPOSURE DURING PREGNANCY (Patient is pregnant) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 29-Oct-2020, Pregnancy test: positive Positive. On 20-Feb-2021, Ultrasound scan: normal (normal) normal.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   It was reported that the patient already gave birth and currently she is in postpartum.  No treatment medications were provided.  Action taken with mRNA-1273 in response to the events was not applicable.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Most recent FOLLOW-UP information incorporated above includes: On 02-Aug-2021: Follow-up received on 02-Aug-2021 and included information about patient pregnancy and birth of her child.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension and Prediabetes.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen). At the time of the report, VACCINATION SITE PRURITUS (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen), VACCINATION SITE ERYTHEMA (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) and VACCINATION SITE SWELLING (In the arm were the injection was administered, a hot red mark appeared that is itchy and a little swollen) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications included medication for hypertension and prediabetes.  No treatment information was provided.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Burning sensation, Poor quality sleep
Clinical narrative: Face burning; Poor sleep; This spontaneous case was reported by a consumer and describes the occurrence of BURNING SENSATION (Face burning) and POOR QUALITY SLEEP (Poor sleep) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced BURNING SENSATION (Face burning) and POOR QUALITY SLEEP (Poor sleep). At the time of the report, BURNING SENSATION (Face burning) and POOR QUALITY SLEEP (Poor sleep) had resolved.            No concomitant products were reported.  No treatment information was provided.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pain
Clinical narrative: Arm pain, shoulder pain, armpit pain; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Arm pain, shoulder pain, armpit pain) and CHILLS (Chills) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K20A and 030L20A) for COVID-19 vaccination.     Concurrent medical conditions included Seizure, Acid reflux (oesophageal) and Cholesterol. Concomitant products included PANTOPRAZOLE for Acid reflux (esophageal), LEVETIRACETAM for Seizure, ZOLPIDEM TARTRATE for an unknown indication.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 19-Feb-2021, the patient experienced PAIN (Arm pain, shoulder pain, armpit pain) and CHILLS (Chills). On 21-Feb-2021, CHILLS (Chills) had resolved. At the time of the report, PAIN (Arm pain, shoulder pain, armpit pain) had not resolved.            Action taken with mRNA-1273 in response to the events was not applicable.   This case was linked to MOD-2021-059497 (Patient Link).
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On 02-Apr-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine administered after temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Warm Transferred from Moderna Customer Care Case No.00135704. HCP reported on 02Apr2021 that they had power outage on 02Apr2021 and vials were in Freezer and Refrigerator where Temperature dropped to : Frozen Vaccine 47Minutes -13.79 C Refrigerator 59 Minutes 12 C and effected vials are: Lot no 003B21A, 100 doses Lot no 027B21A 100 doses Lot no 030B21A 100 doses Lot No 02B21A 140 doses HCP said that 63 doses were administered to 63 Patients. She provided all requested information of patients who received the effected Vaccine.  No concomitant medications were provided.; Sender's Comments: This report refers to a case of Expired Product Administered for mRNA-1273 (Lot #: 003B21A)  with no associated adverse events.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy, Pregnancy test, Ultrasound scan
Clinical narrative: Pregnant caller received both doses of the Moderna vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Pregnant caller received both doses of the Moderna vaccine) in a 34-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on 29-Jan-2021 and the estimated date of delivery was 05-Nov-2021. On 05-Mar-2021, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Pregnant caller received both doses of the Moderna vaccine). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  fifth week of the pregnancy.  On 05-Mar-2021, MATERNAL EXPOSURE DURING PREGNANCY (Pregnant caller received both doses of the Moderna vaccine) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Mar-2021, Pregnancy test: positive (Positive) Positive. On 01-Apr-2021, Ultrasound scan: normal (normal) Everything OKAY.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported by patient.  This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.  Treatment of this event was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 02-Apr-2021: Updated Pregnancy Information - added prospective, pregnancy test, ultrasound scan, para to 0, birth type, fetal outcome; Sender's Comments: This is a case of product exposure during pregnancy with no associated AEs for this 34-year-old female patient. Patient will continue to be contacted for further monitoring of AEs during the pregnancy.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Pruritus, Rash, Rash papular, Urticaria
Clinical narrative: Very strong itchiness with raised bumps; Hhives/urticaria; Raised bumps; Very uncomfortable; Rash all over the body; Rash worsened; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PRURITUS (Very strong itchiness with raised bumps), URTICARIA (Hhives/urticaria), RASH PAPULAR (Raised bumps), FEELING ABNORMAL (Very uncomfortable) and RASH (Rash all over the body) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 014M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 05-Apr-2021, the patient experienced RASH (Rash worsened). On an unknown date, the patient experienced PRURITUS (Very strong itchiness with raised bumps), URTICARIA (Hhives/urticaria), RASH PAPULAR (Raised bumps), FEELING ABNORMAL (Very uncomfortable) and RASH (Rash all over the body). At the time of the report, PRURITUS (Very strong itchiness with raised bumps), URTICARIA (Hhives/urticaria) and FEELING ABNORMAL (Very uncomfortable) outcome was unknown and RASH PAPULAR (Raised bumps), RASH (Rash all over the body) and RASH (Rash worsened) was resolving.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  Treatment information included benadryl 25 mg and prednisone.  On 05 Apr 2021 at 01:00 am, the rash had worsen and the patient ended up going to emergency room and was observed for two hours, and then released.  Action taken with mRNA-1273 in response to the events was not applicable.   Most recent FOLLOW-UP information incorporated above includes: On 07-Apr-2021: Follow up was received on 07 Apr 2021, which consist of update contact information, new event rash aggravated and treatment information.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Dyspnoea, Erythema, Fatigue, Headache
Clinical narrative: he is ill; Unable to breathe; stomach pain which is awful; double vision; sweaty; achy; swelling and hardness and redness at injection site; red face; sore throat; skin was white; dizziness; weakness; fever; nausea; chills; joint pain; muscle pain; fatigue; swelling and hardness and redness at injection site; swelling and hardness and redness at injection site; headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Unable to breathe), ILLNESS (he is ill), ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision) and HYPERHIDROSIS (sweaty) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Vomiting since January 2021.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision), HYPERHIDROSIS (sweaty), PAIN (achy), VACCINATION SITE INDURATION (swelling and hardness and redness at injection site), ERYTHEMA (red face), OROPHARYNGEAL PAIN (sore throat), PALLOR (skin was white), DIZZINESS (dizziness), ASTHENIA (weakness), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (swelling and hardness and redness at injection site), VACCINATION SITE SWELLING (swelling and hardness and redness at injection site) and HEADACHE (headache). On 28-Mar-2021, the patient experienced DYSPNOEA (Unable to breathe). On 01-Apr-2021, the patient experienced ILLNESS (he is ill). At the time of the report, DYSPNOEA (Unable to breathe), ILLNESS (he is ill), ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision), HYPERHIDROSIS (sweaty), PAIN (achy), VACCINATION SITE INDURATION (swelling and hardness and redness at injection site), ERYTHEMA (red face), OROPHARYNGEAL PAIN (sore throat), PALLOR (skin was white), DIZZINESS (dizziness), ASTHENIA (weakness), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (swelling and hardness and redness at injection site), VACCINATION SITE SWELLING (swelling and hardness and redness at injection site) and HEADACHE (headache) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: NNI; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: he is ill; Unable to breathe; stomach pain which is awful; double vision; sweaty; achy; swelling and hardness and redness at injection site; red face; sore throat; skin was white; dizziness; weakness; fever; nausea; chills; joint pain; muscle pain; fatigue; swelling and hardness and redness at injection site; swelling and hardness and redness at injection site; headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Unable to breathe), ILLNESS (he is ill), ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision) and HYPERHIDROSIS (sweaty) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039A21A and 010A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Vomiting since January 2021.   On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Mar-2021, the patient experienced ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision), HYPERHIDROSIS (sweaty), PAIN (achy), VACCINATION SITE INDURATION (swelling and hardness and redness at injection site), ERYTHEMA (red face), OROPHARYNGEAL PAIN (sore throat), PALLOR (skin was white), DIZZINESS (dizziness), ASTHENIA (weakness), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (swelling and hardness and redness at injection site), VACCINATION SITE SWELLING (swelling and hardness and redness at injection site) and HEADACHE (headache). On 28-Mar-2021, the patient experienced DYSPNOEA (Unable to breathe). On 01-Apr-2021, the patient experienced ILLNESS (he is ill). At the time of the report, DYSPNOEA (Unable to breathe), ILLNESS (he is ill), ABDOMINAL PAIN UPPER (stomach pain which is awful), DIPLOPIA (double vision), HYPERHIDROSIS (sweaty), PAIN (achy), VACCINATION SITE INDURATION (swelling and hardness and redness at injection site), ERYTHEMA (red face), OROPHARYNGEAL PAIN (sore throat), PALLOR (skin was white), DIZZINESS (dizziness), ASTHENIA (weakness), PYREXIA (fever), NAUSEA (nausea), CHILLS (chills), ARTHRALGIA (joint pain), MYALGIA (muscle pain), FATIGUE (fatigue), VACCINATION SITE ERYTHEMA (swelling and hardness and redness at injection site), VACCINATION SITE SWELLING (swelling and hardness and redness at injection site) and HEADACHE (headache) outcome was unknown.            No relevant concomitant medications were reported.  Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: NNI; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start dates of the events, a causal relationship cannot be excluded.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face
Clinical narrative: Swelling in face; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING FACE (Swelling in face) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 030A21A) for COVID-19 vaccination.  No medical history was provided by the reporter. Concomitant products included FLUOXETINE HYDROCHLORIDE (PROZAC) and ACETYLSALICYLIC ACID (BABY ASPIRIN) for an unknown indication.  On 06-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Jun-2021, the patient experienced SWELLING FACE (Swelling in face). At the time of the report, SWELLING FACE (Swelling in face) outcome was unknown. Not Provided          Relevant concomitant medication was also included blood pressure pill. Treatment medication was not provided. Action taken with mRNA-1273 in response to the events was not applicable.  Based on the current available information and temporal association between the use of the product and the start date of the event, swelling face, a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 02-Jun-2021: Follow-up information received on 02 JUN 2021 and updated adverse reaction verbatim and AR onset date.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, swelling face, a causal relationship cannot be excluded.
Age: 32.0
Sex: M
Vaccine: COVID19
Symptoms: Interchange of vaccine products
Clinical narrative: Thinks son received 2 different vaccines from different manufacturer; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 02-Apr-2021 and was forwarded to Moderna on 02-Apr-2021.    This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer) in a 32-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A or 030M201A and 044A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).   On 23-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer). At the time of the report, INTERCHANGE OF VACCINE PRODUCTS (Thinks son received 2 different vaccines from different manufacturer) had resolved.            Additional information: She is concerned that her son received two different vaccines from different companies such as 1 from Pfizer and 1 Moderna. She wants to verify if this is the case based on the information she has. Dose 1: Left arm, Expiration: 21Aug2021; Dose 2: 23Mar2021, Lot#: 044A21A, Expiration: 31Aug2021, Right Arm vaccinated.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity, Pain in jaw
Clinical narrative: Jaw pain when she goes to eat; Lower calf cramping for a couple of days; Sore arm with her covid vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw pain when she goes to eat), MUSCLE SPASMS (Lower calf cramping for a couple of days) and PAIN IN EXTREMITY (Sore arm with her covid vaccine) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 2101734) for COVID-19 vaccination.    Co-suspect product included non-company product TREPROSTINIL SODIUM for Primary pulmonary hypertension.    Concurrent medical conditions included Pulmonary arterial hypertension. Concomitant products included RIOCIGUAT (ADEMPAS) and MACITENTAN (OPSUMIT) for an unknown indication.   On 13-Mar-2018, the patient started TREPROSTINIL SODIUM (unknown route) 5 mg/kg. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) 1 dosage form. On an unknown date, the patient experienced PAIN IN JAW (Jaw pain when she goes to eat), MUSCLE SPASMS (Lower calf cramping for a couple of days) and PAIN IN EXTREMITY (Sore arm with her covid vaccine). At the time of the report, PAIN IN JAW (Jaw pain when she goes to eat), MUSCLE SPASMS (Lower calf cramping for a couple of days) and PAIN IN EXTREMITY (Sore arm with her covid vaccine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intravenous) was unknown.       Treatment information was not provided.   Reporter did not allow further contact
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Balance disorder, Myalgia, Product dose omission issue, Tinnitus, Vertigo
Clinical narrative: Loss of balance; off balance feelings; Recommendation not to receive the second dose; Muscle Pain; Vertigo; Tinnitus ringing in ears; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of TINNITUS (Tinnitus ringing in ears), VERTIGO (Vertigo), BALANCE DISORDER (Loss of balance; off balance feelings), PRODUCT DOSE OMISSION ISSUE (Recommendation not to receive the second dose) and MYALGIA (Muscle Pain) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     Concurrent medical conditions included Hypothyroidism. Concomitant products included THYROID (ARMOUR THYROID) for Hypothyroidism, PROBIOTICS NOS and VACCINIUM MACROCARPON (CRAN MAX) for an unknown indication.    On 26-Mar-2021 at 1:50 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Mar-2021, the patient experienced TINNITUS (Tinnitus ringing in ears). On 06-Apr-2021, the patient experienced VERTIGO (Vertigo) and MYALGIA (Muscle Pain). On 14-May-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Recommendation not to receive the second dose). On an unknown date, the patient experienced BALANCE DISORDER (Loss of balance; off balance feelings). On 14-May-2021, PRODUCT DOSE OMISSION ISSUE (Recommendation not to receive the second dose) had resolved. At the time of the report, TINNITUS (Tinnitus ringing in ears), VERTIGO (Vertigo), BALANCE DISORDER (Loss of balance; off balance feelings) and MYALGIA (Muscle Pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Additional event- 'Product dose omission issue' was added. Event- tinnitus outcome was updated to not recovered/resolved. On 09-Jul-2021: Patient demographics updated in patient tab, concomitant medications updated in products tab, New events have been added, action taken updated to withdrawn
Sex: F
Vaccine: COVID19
Symptoms: Breast pain, Ear pain, Eye pruritus, Fatigue, Lymphadenopathy
Clinical narrative: Left breast pain; Sore throat; Sore ear; Itchiness in ear; Itchiness in throat; Eyes are watery and itchy; Lymph nodes under her arm pit was swollen and painful; Fatigue; Arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting), BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear) and PRURITUS (Itchiness in ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting). On 22-Mar-2021, the patient experienced BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear), PRURITUS (Itchiness in ear), THROAT IRRITATION (Itchiness in throat), EYE PRURITUS (Eyes are watery and itchy), LYMPHADENOPATHY (Lymph nodes under her arm pit was swollen and painful) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of Tylenol every 4 hours. At the time of the report, PAIN IN EXTREMITY (Arm was hurting) was resolving, BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear), PRURITUS (Itchiness in ear), THROAT IRRITATION (Itchiness in throat), EYE PRURITUS (Eyes are watery and itchy) and FATIGUE (Fatigue) outcome was unknown and LYMPHADENOPATHY (Lymph nodes under her arm pit was swollen and painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain in extremity, Pruritus, Throat irritation
Clinical narrative: Left breast pain; Sore throat; Sore ear; Itchiness in ear; Itchiness in throat; Eyes are watery and itchy; Lymph nodes under her arm pit was swollen and painful; Fatigue; Arm was hurting; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm was hurting), BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear) and PRURITUS (Itchiness in ear) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Mar-2021, the patient experienced PAIN IN EXTREMITY (Arm was hurting). On 22-Mar-2021, the patient experienced BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear), PRURITUS (Itchiness in ear), THROAT IRRITATION (Itchiness in throat), EYE PRURITUS (Eyes are watery and itchy), LYMPHADENOPATHY (Lymph nodes under her arm pit was swollen and painful) and FATIGUE (Fatigue). The patient was treated with PARACETAMOL (TYLENOL) at a dose of Tylenol every 4 hours. At the time of the report, PAIN IN EXTREMITY (Arm was hurting) was resolving, BREAST PAIN (Left breast pain), OROPHARYNGEAL PAIN (Sore throat), EAR PAIN (Sore ear), PRURITUS (Itchiness in ear), THROAT IRRITATION (Itchiness in throat), EYE PRURITUS (Eyes are watery and itchy) and FATIGUE (Fatigue) outcome was unknown and LYMPHADENOPATHY (Lymph nodes under her arm pit was swollen and painful) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia
Clinical narrative: Severe shoulder pain; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Severe shoulder pain) in a 20-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced ARTHRALGIA (Severe shoulder pain). The patient was treated with PARACETAMOL (TYLENOL) for Shoulder pain, at an unspecified dose and frequency and IBUPROFEN for Shoulder pain, at an unspecified dose and frequency. At the time of the report, ARTHRALGIA (Severe shoulder pain) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant products were reported.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Dyspnoea, Malaise
Clinical narrative: Diagnosed with COVID; Felt pretty sick; Breathing issues; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Diagnosed with COVID), MALAISE (Felt pretty sick) and DYSPNOEA (Breathing issues) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Jan-2021, the patient experienced COVID-19 (Diagnosed with COVID), MALAISE (Felt pretty sick) and DYSPNOEA (Breathing issues). At the time of the report, COVID-19 (Diagnosed with COVID), MALAISE (Felt pretty sick) and DYSPNOEA (Breathing issues) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant products were reported.  No treatment information was provided.    This case was linked to MOD-2021-067968 (Patient Link).
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: A little pain on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (A little pain on injection site) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Broken leg since 08-Dec-2020. Concomitant products included NAPROXEN SODIUM (ALEVE) for Broken leg.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In March 2021, the patient experienced VACCINATION SITE PAIN (A little pain on injection site). In March 2021, VACCINATION SITE PAIN (A little pain on injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling face, Swollen tongue, Taste disorder
Clinical narrative: he experienced bad taste for minute or two; swelling around tongue; swelling around cheek; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported.).    On 14-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Mar-2021, the patient experienced TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek). On 14-Mar-2021, TASTE DISORDER (he experienced bad taste for minute or two), SWOLLEN TONGUE (swelling around tongue) and SWELLING FACE (swelling around cheek) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  The caller was calling on behalf of her brother and wanted to knowif the symptoms reported were normal,  if any medications could be recommended , or if Benadryl (diphenhydramine) could be taken half an hour before receiving the second dose of vaccine, scheduled on11-Apr-2021.  No treatment information was reported.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Pain in extremity
Clinical narrative: Acute periods of heightened sense of smell; severe restless legs symptoms; This spontaneous case was reported by a consumer and describes the occurrence of DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms). At the time of the report, DYSMENORRHOEA (Acute periods of heightened sense of smell) and PAIN IN EXTREMITY (severe restless legs symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant information was not provided. Treatment received APPLE CIDER VINEGAR .   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Non-significant follow-up case booked inAE contact information was updated.contact information updated. She prefers being contacted via email.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Eye swelling, Periorbital swelling, Swelling face
Clinical narrative: swelling in the face especially around the eyes especially when she wakes up; eyes are almost swollen shut; overall puffy; This spontaneous case was reported by a nurse and describes the occurrence of SWELLING FACE (swelling in the face especially around the eyes especially when she wakes up), EYE SWELLING (eyes are almost swollen shut) and PERIORBITAL SWELLING (overall puffy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product HYALURONIC ACID, LIDOCAINE (RESTYLANE L) for an unknown indication.    The patient's past medical history included No adverse event (no medical history reported.).   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form and HYALURONIC ACID, LIDOCAINE (RESTYLANE L) (unknown route) dosage form. On an unknown date, the patient experienced SWELLING FACE (swelling in the face especially around the eyes especially when she wakes up), EYE SWELLING (eyes are almost swollen shut) and PERIORBITAL SWELLING (overall puffy). At the time of the report, SWELLING FACE (swelling in the face especially around the eyes especially when she wakes up), EYE SWELLING (eyes are almost swollen shut) and PERIORBITAL SWELLING (overall puffy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  On an unspecified date, female patient was injected with Restylane Lyft (hyaluronic acid, lidocaine) via cannula into the cheek areas and complained of swelling in the face especially around the eyes, especially when she woke up. She stated that her eyes were almost swollen shut and she was overall puffy. She was vaccinated prior to the injection.  No treatment information was reported.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 49.0
Sex: F
Vaccine: COVID19
Symptoms: Product storage error
Clinical narrative: Vaccine administered after temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) in a 49-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 003B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, the patient experienced PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion). On 02-Apr-2021, PRODUCT STORAGE ERROR (Vaccine administered after temperature excursion) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   It was reported that there was a power outage on 02-Apr-2021 and vials were in freezer and refrigerator where Temperature dropped to -13.79 C for 47 minutes and 12 C for 59 minutes respectively.  No concomitant products were reported.  No treatment information was provided.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Headache, Hypoaesthesia eye, Muscular weakness, Pain in extremity
Clinical narrative: it seems like it is getting worse; today i had numbness (in her eyes); blurring in my eyes; leg is sore and stuff; had a reaction to the vaccine; weakness in the left leg; leg has been swollen; really bad headaches; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), HYPOAESTHESIA EYE (today i had numbness (in her eyes)) and VISION BLURRED (blurring in my eyes) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. O3OA21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Medical history was not reported.  Concomitant products included ASPIRIN [ACETYLSALICYLIC ACID] for an unknown indication.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Mar-2021, the patient experienced VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), PAIN IN EXTREMITY (leg is sore and stuff) and HEADACHE (really bad headaches). On 02-Apr-2021, the patient experienced HYPOAESTHESIA EYE (today i had numbness (in her eyes)) and VISION BLURRED (blurring in my eyes). On an unknown date, the patient experienced CONDITION AGGRAVATED (it seems like it is getting worse). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN at a dose of 1 UNK. At the time of the report, VACCINATION COMPLICATION (had a reaction to the vaccine), MUSCULAR WEAKNESS (weakness in the left leg), PERIPHERAL SWELLING (leg has been swollen), HYPOAESTHESIA EYE (today i had numbness (in her eyes)), VISION BLURRED (blurring in my eyes), PAIN IN EXTREMITY (leg is sore and stuff), CONDITION AGGRAVATED (it seems like it is getting worse) and HEADACHE (really bad headaches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications reported include high blood pressure medication,high cholesterol medication.   Most recent FOLLOW-UP information incorporated above includes: On 14-May-2021: Reporter Contact information updated.